Adam Burns

1.3k total citations
18 papers, 412 citations indexed

About

Adam Burns is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Adam Burns has authored 18 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 7 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Adam Burns's work include Chronic Lymphocytic Leukemia Research (10 papers), Immunodeficiency and Autoimmune Disorders (5 papers) and Cancer Genomics and Diagnostics (5 papers). Adam Burns is often cited by papers focused on Chronic Lymphocytic Leukemia Research (10 papers), Immunodeficiency and Autoimmune Disorders (5 papers) and Cancer Genomics and Diagnostics (5 papers). Adam Burns collaborates with scholars based in United Kingdom, Belgium and Spain. Adam Burns's co-authors include Anna Schuh, Ruth Clifford, Adele Timbs, Jenny C. Taylor, Shirley Henderson, Jennifer Becq, David Bentley, Stephan M. Feller, Lisa Murray and Russell Grocock and has published in prestigious journals such as Blood, Cancer Research and British Journal of Haematology.

In The Last Decade

Adam Burns

14 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Burns United Kingdom 8 250 187 148 105 100 18 412
Ruth Clifford United Kingdom 10 280 1.1× 238 1.3× 149 1.0× 105 1.0× 67 0.7× 28 470
Adele Timbs United Kingdom 10 313 1.3× 179 1.0× 135 0.9× 111 1.1× 174 1.7× 25 504
Dominique Penther France 12 258 1.0× 239 1.3× 104 0.7× 41 0.4× 122 1.2× 32 440
Panagiotis Baliakas Sweden 11 312 1.2× 224 1.2× 113 0.8× 32 0.3× 95 0.9× 34 443
Pascaline Etancelin France 9 125 0.5× 162 0.9× 107 0.7× 50 0.5× 154 1.5× 27 360
Nikos Papakonstantinou Greece 12 284 1.1× 182 1.0× 182 1.2× 66 0.6× 42 0.4× 29 487
Nadia Peragine Italy 15 310 1.2× 212 1.1× 193 1.3× 82 0.8× 110 1.1× 34 605
Carmela Ciardullo Italy 9 356 1.4× 283 1.5× 129 0.9× 66 0.6× 51 0.5× 19 476
Koorosh Korfi United Kingdom 8 151 0.6× 85 0.5× 228 1.5× 81 0.8× 241 2.4× 18 549
Lisa Kujawski United States 13 359 1.4× 189 1.0× 313 2.1× 74 0.7× 255 2.5× 21 753

Countries citing papers authored by Adam Burns

Since Specialization
Citations

This map shows the geographic impact of Adam Burns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Burns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Burns more than expected).

Fields of papers citing papers by Adam Burns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Burns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Burns. The network helps show where Adam Burns may publish in the future.

Co-authorship network of co-authors of Adam Burns

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Burns. A scholar is included among the top collaborators of Adam Burns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Burns. Adam Burns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Willenbrock, Frances, Andrew Blake, Adam Burns, et al.. (2019). Abstract PR02: Loss of TET2 activity results in epigenetic instability and drives PDAC molecular subtypes. Cancer Research. 79(24_Supplement). PR02–PR02. 1 indexed citations
3.
Ridout, Kate, Pauline Robbe, Dimitris Vavoulis, et al.. (2018). The Genomic Landscape of Chronic Lymphocytic Leukaemia: Clinical Implications. Clinical Lymphoma Myeloma & Leukemia. 18. S112–S115. 1 indexed citations
4.
Burns, Adam, David Bruce, Pauline Robbe, et al.. (2018). Detection of Clinically Relevant Molecular Alterations in Chronic Lymphocytic Leukemia (CLL) By Nanopore Sequencing. Blood. 132(Supplement 1). 1847–1847. 1 indexed citations
5.
Klintman, Jenny, Samantha J.L. Knight, Pauline Robbe, et al.. (2018). Clinical‐grade validation of whole genome sequencing reveals robust detection of low‐frequency variants and copy number alterations in CLL. British Journal of Haematology. 182(3). 412–417. 11 indexed citations
6.
Stamatopoulos, Basile, Adele Timbs, Tom Smith, et al.. (2016). Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia. Leukemia. 31(4). 837–845. 37 indexed citations
7.
Robbe, Pauline, Kate Ridout, Jennifer Becq, et al.. (2016). Identifying High-Risk CLL to Predict Early Relapse after FCR Based Treatment Using Whole Genome Sequencing: First Results from the Genomics England CLL Pilot. Blood. 128(22). 2022–2022. 1 indexed citations
8.
9.
Pellagatti, Andrea, S. Roy, Cristina Di Genua, et al.. (2015). 52 TARGETED RE-SEQUENCING ANALYSIS OF 31 GENES COMMONLY MUTATED IN MYELOID DISORDERS IN SERIAL SAMPLES FROM MYELODYSPLASTIC SYNDROME PATIENTS WITH DISEASE PROGRESSION. Leukemia Research. 39. S24–S25. 1 indexed citations
10.
Hamblin, Angela, Adam Burns, Ruth Clifford, et al.. (2014). Development and Evaluation of the Clinical Utility of a Next Generation Sequencing (NGS) Tool for Myeloid Disorders. Blood. 124(21). 2373–2373. 1 indexed citations
11.
12.
Fernández‐Mercado, Marta, Andrea Pellagatti, Cristina Di Genua, et al.. (2013). MUTATIONS IN SETBP1 GENE ARE RECURRENT IN MYELODYSPLASTIC SYNDROMES AND OFTEN COEXIST WITH CYTOGENETIC MARKERS ASSOCIATED WITH POOR PROGNOSIS. Haematologica. 98. 482–482.
13.
Robbe, Pauline, Adele Timbs, Adam Burns, et al.. (2013). COMPREHENSIVE GENOME-WIDE ANALYSIS OF CLL SAMPLES FROM UK 1ST LINE AND RELAPSED/REFRACTORY CLINICAL TRIALS. Haematologica. 98. 241–241.
14.
Mead, Adam J., Onima Chowdhury, C. Pecquet, et al.. (2013). Impact of isolated germline JAK2V617I mutation on human hematopoiesis. Blood. 121(20). 4156–4165. 35 indexed citations
15.
Fernández‐Mercado, Marta, Adam Burns, Andrea Pellagatti, et al.. (2013). Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes. Haematologica. 98(12). 1856–1864. 21 indexed citations
16.
Fernández‐Mercado, Marta, Andrea Pellagatti, Cristina Di Genua, et al.. (2013). Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression. British Journal of Haematology. 163(2). 235–239. 35 indexed citations
17.
Knight, Samantha J.L., Christopher Yau, Ruth Clifford, et al.. (2012). Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia. Leukemia. 26(7). 1564–1575. 45 indexed citations
18.
Schuh, Anna, Jennifer Becq, Sean Humphray, et al.. (2012). Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns. Blood. 120(20). 4191–4196. 214 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruth Clifford Breakdown of academic impact, for papers by Adele Timbs Breakdown of academic impact, for papers by Dominique Penther Breakdown of academic impact, for papers by Panagiotis Baliakas Breakdown of academic impact, for papers by Pascaline Etancelin Breakdown of academic impact, for papers by Nikos Papakonstantinou Breakdown of academic impact, for papers by Nadia Peragine Breakdown of academic impact, for papers by Carmela Ciardullo Breakdown of academic impact, for papers by Koorosh Korfi Breakdown of academic impact, for papers by Lisa Kujawski
Rankless by CCL
2026